Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Assets (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Non-Current Assets data on record, last reported at $4.8 million in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 26.92% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $20.4 million, up 9.29%, while the annual FY2024 figure was $5.4 million, 0.13% changed from the prior year.
  • Non-Current Assets reached $4.8 million in Q3 2025 per GOSS's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $13.9 million in Q1 2022 and bottomed at $2.5 million in Q2 2024.
  • Average Non-Current Assets over 4 years is $7.5 million, with a median of $6.4 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: plummeted 69.59% in 2024, then skyrocketed 97.52% in 2025.
  • A 4-year view of Non-Current Assets shows it stood at $10.6 million in 2022, then plummeted by 48.94% to $5.4 million in 2023, then increased by 0.13% to $5.4 million in 2024, then decreased by 10.6% to $4.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $4.8 million in Q3 2025, $5.0 million in Q2 2025, and $5.1 million in Q1 2025.